SCHEMBL232146

SCHEMBL232146

CCCCCCCCCCCCCCCCC(O)C(=O)OCC(CC)CCCC

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.58
TSHR P16473 3/20 0.58
TDP1 Q9NUW8 2/20 0.58
ATM Q13315 1/20 0.58
PRSS1 P07477 1/20 0.56
PRSS2 P07478 1/20 0.56
PRSS3 P35030 1/20 0.56
RECQL P46063 1/20 0.52
ALDH1A1 P00352 4/20 0.51
CA2 P00918 2/20 0.51
GPR84 Q9NQS5 3/20 0.50
FFAR1 O14842 1/20 0.50
LMNA P02545 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ZDHHC7 Q9NXF8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695574 0.91 GPR84 (0.55) CYP3A4TSHRTDP1ATMPRSS1
Benzoic Acid SCHEMBL5575037 0.85 PRSS1 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL2902800 0.85 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL29195736 0.85 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL6239514 0.85 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL4340497 0.85 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL187080 0.85 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL13799407 0.84 CYP3A4 (0.64) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL7223059 0.83 CYP3A4 (0.58) CYP3A4TSHRTDP1ATMPRSS1
SCHEMBL7218092 0.83 PRSS1 (0.60) CYP3A4TSHRTDP1ATMPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 641 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118078649-A Microcapsules, method for preparing same, and non-cosmetic composition comprising a plurality of microcapsules 塔格拉生物技术有限公司 2024-05-28 CN claimed
EP-3344220-B1 MICROCAPSULES ENCAPSULATING A REFLECTIVE AGENT TAGRA BIOTECHNOLOGIES LTD (IL) 2024-05-08 EP claimed
EP-3784706-B1 PREPARATION OF AN ACTIVE POLYMER EMULSION COATEX SAS (FR) 2024-04-03 EP claimed
CN-107921289-B Water-in-oil emulsion comprising microcapsules encapsulating an oily dispersion of at least one reflecting agent for caring for and/or making up keratin materials 莱雅公司 2023-09-22 CN claimed
CN-114269816-B Porous cellulose microparticles and process for producing the same 阿诺米拉公司 2023-09-19 CN claimed
CN-114269816-A Porous cellulose microparticles and method for producing same 阿诺米拉公司 2022-04-01 CN claimed
EP-3966277-A1 POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF Anomera Inc. (CA) 2022-03-16 EP claimed
US-11065593-B2 Microcapsules encapsulating a reflective agent TAGRA BIOTECHNOLOGIES LTD. (IL) 2021-07-20 US claimed
CN-107921291-B Oil-in-water emulsion comprising microcapsules encapsulating an oily dispersion of at least one reflecting agent for caring for and/or making up keratin materials 莱雅公司 2021-07-06 CN claimed
EP-3784706-A1 PREPARATION OF AN ACTIVE POLYMER EMULSION Coatex (FR) 2021-03-03 EP claimed
CN-102481232-A Emulsion containing bismuth oxychloride dispersion OREAL 2012-05-30 CN claimed
US-20120003172-A1 USE OF VOLATILE LINEAR ALKANE(S) AND LIQUID FATTY ESTER(S) IN AN ANHYDROUS MEDIUM FOR THE TREATMENT OF KERATIN FIBRES, AND AN ANHYDROUS COMPOSITION BASED ON VOLATILE LINEAR ALKANE(S), LIQUID FATTY ESTER(S) AND PARTICULAR OIL(S) L'OREAL (FR) 2012-01-05 US claimed
EP-1614411-B1 OILY MAKEUP COSMETICS KANEBO COSMETICS INC (JP) 2011-10-05 EP claimed
US-7417162-B2 Oily ingredient for cosmetic preparation and cosmetic preparation KYOWA YUKA CO., LTD. (JP) 2008-08-26 US claimed
US-6869597-B2 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL S.A. (FR) 2005-03-22 US claimed
US-20040166130-A1 Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester L'OREAL (FR) 2004-08-26 US claimed
US-20030077234-A1 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group L'OREAL. 2003-04-24 US claimed
US-RE33429-E Crosslinked polymer beAD DOW CORNING CORPORATION (US) 1990-11-06 US claimed
US-4724240-A Lattice-entrapped emollient-moisturizer composition WICKHEN PRODUCTS, INC. (US) 1988-02-09 US claimed
EP-0061701-A2 A solid entrapped emollient-moisturizer composition and the use thereof Wickhen Products, Inc. (US) 1982-10-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040166130-A1 Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester CYP51A1, ELOVL3, ELOVL5 CYP3A4 696/4885TSHR 4731/4885TDP1 1236/4885
US-20030077234-A1 Cosmetic care or makeup composition for a keratin material comprising at least one photoprotective agent and at least one ester comprising an aromatic group KRT18, CUTA, TYR CYP3A4 1988/4885TSHR 2942/4885TDP1 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.